Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 721-727

  Yamada, Shizuo ^a   Uchida, Shinya ^a   Ohkura, Takashi ^a   Kimura, Ryohei ^a   Yamaguchi, Masayoshi ^a   Suzuki, Masanori ^b   Yamamoto, Minoru ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; CONOTOXIN; NICARDIPINE; NILVADIPINE; NIMODIPINE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BRAIN CORTEX; BRAIN METABOLISM; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DRUG BINDING SITE; NERVE DEGENERATION; NERVE FUNCTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SENESCENCE; SENILE DEMENTIA; STATE DEPENDENT LEARNING;

AGING; ANIMALS; BINDING SITES; BRAIN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; ISRADIPINE; MICE; NICARDIPINE; NIMODIPINE; OMEGA-CONOTOXIN GVIA; PEPTIDES;

EID: 0030424506     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. CAHN, J. AND BORZWEIX, M. G.: Water, electrolytes contents of the brain and cerebral function in aged rats. Monogr. Neural Sci. 11: 85-92, 1984.
2. 3H]PY108-068. J. Neural Transm. 60: 169-197, 1984.
3. 125I]ω-conotoxin GVIA binding sites in the rat frontal cortex and caudate nucleus. Brain Res. 583: 189-193, 1992.
4. DEYO, R. A., STRAUBE K. T. AND DISTERHOFT, J. F.: Nimodipine facilitates associative learning in aging rabbits. Science (Wash. DC) 243: 809-811, 1989.
5. FERRANTE, J. AND TRIGGLE, D. J.: Drug- and disease-induced regulation of voltage-dependent calcium channels. Pharmacol. Rev. 42: 29-44, 1990.
6. 2+ homeostasis in dementia. Mech. Find. Exp. Clin. Pharmacol. 15: 549-555, 1993.
7. GIBSON, G. E. AND PETERSON, C.: Calcium and the aging nervous system. Neurobiol. Aging 8: 329-343, 1987.
8. 3H]dopa in various regions of the brain. J. Neurochem. 13: 655-669, 1966.
9. HESS, P., LANSMAN, J. B. AND TSIEN, R. W.: Different modes of Ca channel gating behavior favored by dihydropyrioine Ca agonists and antagonists. Nature (Lond.) 311: 538-544, 1984.
10. HIGUCHI, K., MATSUMURA, A., HONMA, A., TAKESHITA, S., HASHIMOTO, K., HOSOKAWA, M., YASUHIRA, K. AND TAKEDA, T.: Systemic senile amyloid in senescence-accelerated mouse. An unique fibril protein demonstrated in tissues from various organs by unlabeled immunoperoxidase method. Lab. Invest. 48: 231-240, 1983.
11. HOLLENBERG, M. D.: Examples of homospecific and heterospecific receptor regulation. Trends Pharmacol. Sci. 6: 242-245, 1985.
12. KABUTO, H., YOKOI, T., MORI, A., MUSAKAMI, M. AND SAWADA, S.: Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine. Mech. Ageing Dev. 80: 1-9, 1995.
13. 3H]nitrendipine to cerebral cortical and hippocampal membranes of senescence accelerated mouse. Neurosci Lett. 106: 334-338, 1989.
14. KITAMURA, Y, ZHAO, X.-H., OHNUKI, T., TAKEI, M. AND NOMURA, Y: Age-related changes in transmitter glutamate and NMDA receptor/channels in the brain of senescence-accelerated mouse. Neurosci. Lett. 137: 169-172, 1992.
15. LANDFIELD, P. W., APPLEGATE, M. D., SCHWITZER-OSBORNE, S. E. AND NAYLOR, C. E : Phosphate/calcium alterations in the first stages of Alzheimer's disease: Implications for etiology and pathogenesis. J. Neurol. Sci. 106: 221-229, 1991.
16. 3H]PN 200-110 binding to dihydropyridine receptors associated with channels in rat cerebral cortex and heart. Life Sci. 35: 721-732, 1984
17. LOWRY, O. H , ROSENBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
18. MARTINEZ, A., VICTORICA, J., BOGONEZ, E. AND SATRUSTEGUI, J.: Differential effects of age on the pathways of calcium influx into nerve terminals. Brain Res 435: 249-257, 1987.
19. MARTINEZ, A., VICTORICA, J. AND SATRUSTEGUI, J.: Cytosolic free calcium levels increase with age in rat brain synaptosomes. Neurosci. Lett. 88: 336-342, 1988.
20. MILLER, R. J.: Multiple calcium channels and neuronal function. Science (Wash. DC) 235: 46-62, 1987.
21. 3H]glib-enclamide binding in normal and cardiomyopathic hamsters. Gen. Pharmacol. 23: 1153-1157, 1992.
22. MIYAMOTO, M., KIYOTA, Y, YAMAZAKI, N., NAGAOKA, A., MATSUO, T. NAGAMA, Y. AND TAKEDA, T.: Age-related changes in learning and memory in the senescence-accelerated mouse (SAM). Physiol. Behav. 38: 399-406, 1986.
23. NOMURA, Y, KITAMURA, Y. AND ZHAO X.-H.: Aging in the glutamatergic system with special reference to the NMDA receptor/ion channel complex in the brains of senescence accelerated mice. In NMDA Receptor Related Agents: Biochemistry, Pharmacology and Behavior, ed. by T. Kameyama, T. Nabeshima and E. F. Domino, pp. 287-298, NPP Books, MI, 1991.
24. NOVI, I.: Calcium et le magnesium du cervaedans des differents ages. Arch. Ital. Biol. 58: 333-336, 1912.
25. NOWYCKY, M. C., FOX, A. P. AND TSIEN, R. W.: Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature (Lond) 316: 440-443, 1985.
26. 3H-nitrendipine recognition sites in mouse brain after long-term treatment with nifedipine or verapamil. Neuropharmacol. 24: 1113-1117, 1985.
27. 3H]Nitrendipine binding in temporal cortex in Alzheimer's and Huntington's diseases. Brain Res. 565: 42-47, 1991.
28. REYNOLDS, I. J., WAGNER, J. A., SNYDER, S. H., THAYER, S. A., OLIVERA, B. M. AND MILLER, R. J., Brain voltage-sensitive calcium channel subtypes differentiated by ω-conotoxin fraction GVIA. Proc. Natl. Acad. Sci. U.S.A 83: 8804-8807, 1986.
29. ROSENTHAL, H. E.: Graphic method for the determination and presentation of binding parameters in a complex system. Anal. Biochem. 20: 525-532, 1967.
30. SANGUINETTI, M. C. AND KASS, R. S.: Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channels antagonists. Cir. Res. 55: 336-348, 1984.
31. SCHUURMAN, T., HORVATH, E., SPENCER D G. JR. AND TRAVER, J.: Nimodipine and motor deficits in the aged rat. Neurosci. Res. Comm.: 1: 9-15, 1987.
32. SCRIABINE, A., SCHUURMAN, T. AND TEAVER, J.: Pharmacological basis for the use of nimodipine in central nervous system disorders. FASEB J. 3: 1799-1806, 1989.
33. SIMMS, H. S. AND STOLMAN, T.: Changes in human tissue electrolytes in senescence. Science (Wash. DC) 86: 269-270, 1937.
34. TAKEDA, T., HOSOKAWA, S., TAKESHITA, M., IRINO, K., HIGUCHI, M., MATSUSHITA, Y., TOMITA, Y, YASUHIRA, K., HAMAMOTO, H., SHIMIZU, K., ISHII, M. AND YAMAMURA, T.: A new murine model of accelerated senescence. Mech. Ageing Dev. 17: 183-194, 1981.
35. UCHITEL, O. D., PROTTI, D. A., SANCHEZ, V., CHERKREY, B. D., SUGIMORI, M. AND LLINAS, R.: P-type voltage-dependent calcium channel mediates presynaptic calcium efflux and transmitter release in mammalian synapses. Proc. Natl. Acad. Sci. U.S.A 89: 3330-3333, 1992.
36. VANHOUTTE, P., PAOLETTI, R. AND GORONI, S.: Calcium antagonists. Pharmacology and clinical research. Ann. N. Y. Acad. Sci. 522: 638-731, 1988.
37. YAGI, H., KATOH, S., AKIGUCHI, I. AND TAKEDA, T.: Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Brain Res. 474: 86-93, 1988.
38. YAGI, H., IRMO, T., MATSUSHITA, T., KATOH, S., UMEZAWA, M., TSUBOYAMA, T., HOSOKAWA, M., AKIGUCHI, I., TOKUNAGA, R. AND TAKEDA, T.: Spontaneous spongy degeneration of the brain stem in SAM-P/8 mice, a newly developed memory-deficient strain J. Neuropathol. Exp. Neurol. 48: 577-590, 1989.
39. 3H]PN 200-110 in coronary artery. J. Pharmacol. Exp. Ther. 252: 327-332, 1990.
40. YAMADA, S., SUGIMOTO, N., UCHIDA, S., DEGUCHI, Y. AND KIMURA, R.: Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors. J. Cardiovasc. Pharmacol. 23: 466-472, 1994.
41. YAMADA, S., YAMAMURA, H. I. AND ROESKE, W. R.: Alteration in cardiac autonomic receptors following 6-hydroxydopamine treatment in rats. Mol. Pharmacol. 18: 185-192, 1980.
42. YAMAGUCHI, M., TAKEI, Y. AND YAMAMOTO, T.: Effects of thyrocalcitonin on calcium concentrations in liver of intact and thyroparathyroidectomized rats. Endocrinology 96: 1004-1008, 1975.
43. 2+ antagonists on changes in brain function in senescence-accelerated mice (Abstract). 24th Ann. Meeting on Amer. Soc. Neurosci. p 392, 1994.
44. YAMAMOTO, M., SUZUKI, M., OZAWA, Y, UCHIDA, S., YAMADA, S. AND KIMURA, R.: Effects of calcium channel blockers on impairment of brain function in senescence-accelerated mice. Arch. int. Pharmacodyn. Ther. (in press).